Patents by Inventor Jens C. Jensenius

Jens C. Jensenius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibody specific for a human tumour-associated antigen
    Patent number: 5338661
    Abstract: The present invention provides a human monoclonal antibody (C-OU1) which specifically binds a human adenocarcinoma tumor-associated antigen with an apparent molecular weight of about 43 kD and an isoelectric point of about 5.4-6.2. Screening assays using the antibody are also disclosed.
    Type: Grant
    Filed: September 29, 1989
    Date of Patent: August 16, 1994
    Inventors: Jens C. Jensenius, Per Borup-Christensen, Karin Erb
  • Methods of treating disorders which cause conglutinin deficiency
    Patent number: 5132287
    Abstract: Human conglutinin, polyclonal, and monoclonal antibodies raised against human conglutinin, and their uses in therapy and diagnosis are described.Human conglutinin was obtained from human plasma by affinity chromatography with anti-bovine conglutinin antibody, has a relative molecular weight of 330 and 40 K unreduced and 66 K reduced as measured by SDS-PAGE, shows calcium-dependent and sugar inhibitable binding to complement-reacted immune complexes and zymosan, and immunological cross-reaction with anti-bovine conglutinin antibody.
    Type: Grant
    Filed: November 27, 1989
    Date of Patent: July 21, 1992
    Assignee: Novo Industri A/S
    Inventor: Jens C. Jensenius
  • Human conglutinin
    Patent number: 4906734
    Abstract: Human conglutinin, polyclonal, and monoclonal antibodies raised against human conglutinin, and their uses in therapy and diagnosis are described.Human conglutinin was obtained from human plasma by affinity chromatography with anti-bovine conglutinin antibody, has a relative molecular weight of 330 and 40 K unreduced and 66 K reduced as measured by SDS-PAGE, shows calcium-dependent and sugar inhibitable binding to complement-reacted immune complexes and zymosan, and immunological cross-reaction with anti-bovine conglutinin antibody.
    Type: Grant
    Filed: December 8, 1986
    Date of Patent: March 6, 1990
    Assignee: Novo Industri A/S
    Inventor: Jens C. Jensenius